Bio Protocol Raises $6.9M: How AI BioAgents Are Set to Disrupt Biotech and DeSci
Bio Protocol just landed $6.9M in funding from heavyweights like Animoca Brands and Arthur Hayes' Maelstrom Fund. Dive into how their AI 'BioAgents' could slash drug discovery timelines and supercharge decentralized science on blockchain.